Bentham Science Logo

CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 18, 10 Issues, 2019
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access

Ranking and Category

  • 150th of 267 in

    Neurosciences

  • 119th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

CNS & Neurological Disorders - Drug Targets , Volume 17 - Number 1


Preface   Free Content


Commentary   Free Content

Commentary: Let the Time Fly: Dopamine is the Arbiter

, 17(1): 3 - 5

Xiaodong Liu, Changzheng Zhang, Oscar Arias-Carrion* and Ti-Fei Yuan*


DOI: 10.2174/1871527316999170505110106




Review Article   Free Content

Antidepressant Potential of Peptides: New Insights as Future Therapeutic

, 17(1): 9 - 13

Haroon Khan*, Sumaira Khattak, Mohammad S. Mubarak, Saud S. Bawazeer, Tareq Abu-Izneid and Mohammad A. Kamal


DOI: 10.2174/1871527316666170731102237



Review Article   Free Content

C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease

, 17(1): 14 - 21

Abdelrahman Ibrahim Abushouk, Ahmed Negida*, Rasha Abdelsalam Elshenawy, Hossam Zein, Ali M. Hammad, Ahmed Menshawy and Wael M.Y. Mohamed


DOI: 10.2174/1871527316666170602101538



Review Article   Free Content

VaD - An Integrated Framework for Cognitive Rehabilitation

, 17(1): 22 - 33

Maria Balea, Dafin Muresanu*, Anton Alvarez, Volker Homberg, Ovidiu Bajenaru, Alla Guekht, Wolf-Dieter Heiss, Livia Popa, Johannes Vester, Ioana Muresanu, Codruta Birle and Dana Slavoaca


DOI: 10.2174/1871527317666180219164545



Review Article   Free Content

Literature Evidence and ARRIVE Assessment on Neuroprotective Effects of Flavonols in Neurodegenerative Diseases' Models

, 17(1): 34 - 42

Ana Carolina Bombardi Duarte, Maycon Giovani Santana, Guilherme di Camilo Orfali, Carlos Tadeu Parisi de Oliveira and Denise Goncalves Priolli*


DOI: 10.2174/1871527317666171221110139



Research Article   Free Content

Development of a Nasal Donepezil-loaded Microemulsion for the Treatment of Alzheimer’s Disease: in vitro and ex vivo Characterization

, 17(1): 43 - 53

Lupe C. Espinoza, Marisol Vacacela, Beatriz Clares*, Maria Luisa Garcia, Maria-Jose Fabrega and Ana C. Calpena


DOI: 10.2174/1871527317666180104122347



Research Article   Free Content

In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease

, 17(1): 54 - 68

Kanzal Iman, Muhammad Usman Mirza*, Nauman Mazhar, Michiel Vanmeert, Imran Irshad and Mohammad A. Kamal


DOI: 10.2174/1871527317666180115162422



Research Article   Free Content

TNF-α Polymorphisms and Maternal Depression in a Mexican Mestizo Population

, 17(1): 69 - 74

Ada Sandoval-Carrillo, Cosme Alvarado-Esquivel, Carlos Salas-Martinez, Edna M. Mendez-Hernandez, Antonio Sifuentes-Alvarez, Ana L. Martínez-Martinez, Juan M. Castillo-Orona, Jesus Hernandez-Tinoco, Elizabeth I. Antuna-Salcido, Luis F. Sanchez-Anguiano, Lilia M. Velez Velez, Sergio M. Salas-Pacheco, Francisco X. Castellanos-Juarez, Osmel La Llave-Leon, Oscar Arias-Carrion* and Jose M. Salas-Pacheco*


DOI: 10.2174/1871527317666180207165238





Editor-in-Chief

Cesar V. Borlongan
Department of Neurosurgery and Brain Repair
University of South Florida Morsani College of Medicine
Tampa, FL
USA

Biography View Full Editorial Board

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.13

Related Journals

Related eBooks

eBooks Catalog